Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
INM
$1.30
-2.26%
INM
· InMed Pharmaceuticals Inc.
$1.30
-0.03 (-2.26%)
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— flagged Sep 9, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We have concluded that there is substantial doubt about our ability to continue as a going concern within one year after the date that the consolidated financial statements are issued.”View the 10-K filed Sep 9, 2026
Market Cap
$7.58M
Shares
5.49M
Volume · Oct 2
28.34K
Avg daily vol (3M)
916.81K
All webcasts
Earnings call · FY2021 Q1
InMed Pharmaceuticals Inc. (INM) Q1 2021 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Net income
-$1.60M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Nov 13, 2020 · complete as-filed document
SEC periodic report
10-Q report
Filed Dec 17, 2020 · complete as-filed document